Brian Durie

Brian G.M. Durie is a Scottish hematologist known for his research and efforts regarding multiple myeloma and blood disorders, especially his development of the multiple myeloma staging system. He is the Chairman of the Board and Scientific Director for the Myeloma Foundation and a specialist in multiple myeloma and related disorders at the Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute ..

Brian G.M. Durie
Born 1942 (age 7879)

North Berwick, Scotland
Occupation Physician, researcher
Known for
  • Durie-Salmon Staging System
  • International Myeloma Working Group
  • Black Swan Research Initiative
Board member of

. . . Brian Durie . . .

Durie was born December 1942 in Gullane, Scotland..[1] and graduated in 1960 from North Berwick High School.[1] He attended the University of Edinburgh Medical School and graduated in 1966. After Medical and Surgical House Officer positions at the University of Edinburgh Royal Infirmary in 1967,[1] he moved to the United States to complete his medical residency and subspecialty training. His training at Mayo Clinic in Minnesota was completed in 1972[1] and led to Specialty Board Certification in Internal Medicine (ABIM) in 1972 followed by his Certification in Hematology (ABIM) in 1974[1] and Oncology (ABIM) in 1975.[1] Durie obtained his Medical licensure in Minnesota in 1972,[1] Arizona in 1974[1] and California in 1993[1]

Upon completing subspecialty training, Durie joined the Medical Faculty of the University of Arizona College of Medicine – Tucson in 1972 where he progressed to Full Professor status in the Section of Hematology/Oncology in 1981.[1] He served as Head of the Hematology Section and Director of the Myeloma Program.[2] In 1989, he became a professor and Head of the Department of Clinical and Laboratory Hematology at the University of London where he also established a myeloma program.[2] In 1992, he returned to the United States in the Division of Hematology/Oncology at Cedars-Sinai Medical Center in Los Angeles.[3] Upon return to the United States, he assume Directorship of the Hematological Research and Myeloma Programs for Aptium Oncology Inc. (subsequently AMyC Myeloma Consortium)[4] also based at Cedars-Sinai Medical Center in the Comprehensive Cancer Center Division. He currently remains as a myeloma specialist physician[3]

. . . Brian Durie . . .

This article is issued from web site Wikipedia. The original article may be a bit shortened or modified. Some links may have been modified. The text is licensed under “Creative Commons – Attribution – Sharealike” [1] and some of the text can also be licensed under the terms of the “GNU Free Documentation License” [2]. Additional terms may apply for the media files. By using this site, you agree to our Legal pages . Web links: [1] [2]

. . . Brian Durie . . .